-
Something wrong with this record ?
ZnO nanorods functionalized with chitosan hydrogels crosslinked with azelaic acid for transdermal drug delivery
J. Radwan-Pragłowska, Ł. Janus, M. Piątkowski, A. Sierakowska, D. Matysek
Language English Country Netherlands
Document type Journal Article
- MeSH
- Administration, Cutaneous MeSH
- Chitosan * MeSH
- Hydrogels MeSH
- Dicarboxylic Acids MeSH
- Drug Delivery Systems MeSH
- Humans MeSH
- Mice MeSH
- Zinc Oxide * MeSH
- Drug Liberation MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
The growing number of people suffering from civilization diseases increases the amount of medication taken. Thus, novel methods for drug delivery must be developed which will constitute an alternative to oral administration. A new hope for patients bring transdermal drug delivery systems. To overcome skin barrier function, they must be prepared from materials which increase cell membrane permeability for the medication. Therefore, there is an increasing need for novel, advanced transdermal systems capable of controlled active substance release under specific stimuli. The aim of this research was to obtain novel hydrogel-based transdermal delivery systems through crosslinking process of chitosan using azelaic acid followed by doping with ZnO nanorods to enhance its drug sorption properties. Ready materials were investigated over their structure, morphology and durability. Drug loading capacity, controlled drug release ability and its kinetics were determined on medication used in treatment of cardiovascular system diseases - acetylsalicylic acid. Finally, lack of cytotoxicity was confirmed by XTT assay and cell morphology study carried out on L929 mouse fibroblasts. Obtained results show a great potential of the developed transdermal delivery systems in active substances administration through skin tissue and may help to protect digestive tract of the patients in the future.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21020028
- 003
- CZ-PrNML
- 005
- 20210830101630.0
- 007
- ta
- 008
- 210728s2020 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.colsurfb.2020.111170 $2 doi
- 035 __
- $a (PubMed)32521459
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Radwan-Pragłowska, Julia $u Department of Physical Chemistry, Faculty of Chemical Engineering and Technology, Cracow University of Technology, Poland
- 245 10
- $a ZnO nanorods functionalized with chitosan hydrogels crosslinked with azelaic acid for transdermal drug delivery / $c J. Radwan-Pragłowska, Ł. Janus, M. Piątkowski, A. Sierakowska, D. Matysek
- 520 9_
- $a The growing number of people suffering from civilization diseases increases the amount of medication taken. Thus, novel methods for drug delivery must be developed which will constitute an alternative to oral administration. A new hope for patients bring transdermal drug delivery systems. To overcome skin barrier function, they must be prepared from materials which increase cell membrane permeability for the medication. Therefore, there is an increasing need for novel, advanced transdermal systems capable of controlled active substance release under specific stimuli. The aim of this research was to obtain novel hydrogel-based transdermal delivery systems through crosslinking process of chitosan using azelaic acid followed by doping with ZnO nanorods to enhance its drug sorption properties. Ready materials were investigated over their structure, morphology and durability. Drug loading capacity, controlled drug release ability and its kinetics were determined on medication used in treatment of cardiovascular system diseases - acetylsalicylic acid. Finally, lack of cytotoxicity was confirmed by XTT assay and cell morphology study carried out on L929 mouse fibroblasts. Obtained results show a great potential of the developed transdermal delivery systems in active substances administration through skin tissue and may help to protect digestive tract of the patients in the future.
- 650 _2
- $a aplikace kožní $7 D000279
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a chitosan $7 D048271
- 650 _2
- $a kyseliny dikarboxylové $7 D003998
- 650 _2
- $a lékové transportní systémy $7 D016503
- 650 _2
- $a uvolňování léčiv $7 D065546
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hydrogely $7 D020100
- 650 _2
- $a myši $7 D051379
- 650 12
- $a oxid zinečnatý $7 D015034
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Janus, Łukasz $u Department of Physical Chemistry, Faculty of Chemical Engineering and Technology, Cracow University of Technology, Poland
- 700 1_
- $a Piątkowski, Marek $u Department of Physical Chemistry, Faculty of Chemical Engineering and Technology, Cracow University of Technology, Poland. Electronic address: marek.piatkowski@pk.edu.pl
- 700 1_
- $a Sierakowska, Aleksandra $u Department of Physical Chemistry, Faculty of Chemical Engineering and Technology, Cracow University of Technology, Poland
- 700 1_
- $a Matysek, Dalibor $u Faculty of Mining and Geology, Technical University of Ostrava, Czech Republic
- 773 0_
- $w MED00180202 $t Colloids and surfaces. B, Biointerfaces $x 1873-4367 $g Roč. 194, č. - (2020), s. 111170
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32521459 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20210830101630 $b ABA008
- 999 __
- $a ok $b bmc $g 1690756 $s 1140474
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 194 $c - $d 111170 $e 20200604 $i 1873-4367 $m Colloids and surfaces. B, Biointerfaces $n Colloids surf., B Biointerfaces $x MED00180202
- LZP __
- $a Pubmed-20210728